Curatis Holding AG (SWX:CURN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
23.30
-2.70 (-10.38%)
Mar 12, 2026, 5:30 PM CET
Market Cap120.09M +120.0%
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out5.15M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,237
Average Volume4,898
Open26.00
Previous Close26.00
Day's Range22.60 - 26.00
52-Week Range9.14 - 27.90
Betan/a
RSI66.44
Earnings Daten/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collage... [Read more]

Sector Healthcare
CEO Roland Rutschmann
Employees 13
Stock Exchange SIX Swiss Exchange
Ticker Symbol CURN
Full Company Profile